Company Filing History:
Years Active: 2013
Title: Michael Schunn: Innovator in Peptide Technology
Introduction
Michael Schunn is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of peptide technology, particularly in the development of pharmaceutical compositions and vaccines. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Michael Schunn holds a patent related to a peptide consisting of one antigen of any of the SEQ ID NOS: 1 to 7 or a functional active variant thereof. This patent also includes a nucleic acid coding for the same, a pharmaceutical composition, especially a vaccine, comprising said peptide or said nucleic acid, and an antibody or functional active fragment thereof specifically binding to the antigen. Additionally, it covers a hybridoma cell line that produces said antibody, methods for producing the antibody, and various uses of the peptide and antibody for immunization, treatment of infections, and diagnostic methods.
Career Highlights
Michael Schunn is currently associated with Intercell Austria AG, where he continues to work on innovative solutions in the field of immunology. His career is marked by a commitment to research and development, contributing to advancements that have the potential to improve healthcare outcomes.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Andreas Meinke and Eszter Nagy. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Michael Schunn's contributions to peptide technology and his innovative patent reflect his commitment to advancing medical science. His work at Intercell Austria AG and collaborations with fellow researchers underscore the importance of teamwork in driving innovation.